Exercise Response Phenotyping for Individualized Care

Abstract

Exercise response phenotyping represents an emerging paradigm in precision medicine, aiming to tailor exercise interventions based on individual physiological, genetic, and molecular profiles. Recent research underscores significant interindividual variability in exercise adaptation, highlighting the need for phenotypic categorization to optimize therapeutic outcomes. This review synthesizes current evidence on mechanisms, clinical applications, and future directions in exercise response phenotyping, emphasizing its growing relevance for individualized care in cardiometabolic, musculoskeletal, and chronic disease populations.

Introduction

The concept of exercise as medicine is well-established, yet clinical outcomes from exercise interventions exhibit notable heterogeneity. Exercise response phenotyping seeks to elucidate the determinants of this variability, incorporating genetic, molecular, and environmental factors to predict and optimize individual responses. The integration of phenotyping into clinical practice promises to enhance efficacy, reduce adverse effects, and inform personalized exercise prescriptions. This article provides a comprehensive review of the disease burden, underlying mechanisms, risk stratification, and current clinical practice regarding exercise response phenotyping, with a focus on evidence-based strategies for individualized care.

Epidemiology / Disease Burden

Physical inactivity remains a leading global health risk, contributing to the burden of cardiovascular disease, obesity, diabetes, and musculoskeletal disorders. Despite strong evidence supporting exercise interventions as primary or adjunct therapy, approximately 20–30% of individuals exhibit suboptimal or adverse responses to standardized regimens. Such variability underscores the need to move beyond the \"one-size-fits-all\" approach, as non-responders or adverse responders may not derive intended benefits, potentially exacerbating health disparities. Epidemiological studies, including the HERITAGE Family Study and large-scale cohort analyses, have delineated the prevalence of differential exercise responsiveness across populations, reinforcing the clinical imperative for phenotyping.

Pathophysiology

Exercise response variability is underpinned by complex interactions among genetic predisposition, epigenetic regulation, proteomics, metabolomics, and environmental exposures. Key mechanisms include differences in cardiorespiratory adaptation, mitochondrial biogenesis, muscle fiber composition, and neurohormonal axis modulation. Variants in genes such as ACTN3, ACE, and PPARGC1A have been implicated in differential responsiveness, affecting aerobic capacity, strength, and metabolic efficiency. Epigenetic modifications, including DNA methylation and histone acetylation, further influence gene expression and adaptation to exercise stimuli. Understanding these mechanisms is pivotal in defining phenotypes predictive of training responsiveness and clinical outcomes.

Risk Factors

Risk stratification for exercise response incorporates both intrinsic and extrinsic factors. Intrinsic factors include age, sex, baseline fitness, comorbidities (e.g., metabolic syndrome, cardiovascular disease), and genetic variants. Extrinsic factors encompass exercise modality, intensity, duration, adherence, nutritional status, and environmental influences. Notably, individuals with underlying chronic diseases or polygenic risk profiles may manifest attenuated or paradoxical responses, necessitating tailored intervention protocols. Identification of these risk factors through comprehensive assessment enables clinicians to anticipate response trajectories and mitigate potential risks.

Clinical Features

Phenotypic characterization involves multidimensional assessment, including physiological (e.g., VO2max, lactate threshold), biochemical (e.g., lipid profile, glycemic control), and functional (e.g., muscle strength, endurance) markers. Clinical features of positive response include improved aerobic capacity, enhanced metabolic health, reduced inflammation, and favorable cardiovascular remodeling. Conversely, non-responders may exhibit blunted improvements or, rarely, adverse responses such as exercise-induced arrhythmias or exacerbation of musculoskeletal symptoms. Advanced phenotyping incorporates wearable sensor data, metabolomic profiling, and continuous monitoring to capture dynamic changes during exercise interventions.

Diagnosis

Diagnostic approaches to exercise response phenotyping integrate baseline assessment, standardized exercise testing, and post-intervention evaluation. Cardiopulmonary exercise testing (CPET), isokinetic dynamometry, blood biomarker analysis, and genetic screening constitute core diagnostic modalities. Emerging tools, such as transcriptomic and metabolomic profiling, facilitate granular phenotypic classification and prediction of response patterns. Diagnostic criteria for non-responsiveness or adverse response are increasingly standardized, based on percentile changes relative to population norms and minimal clinically important differences.

Treatment & Management

Individualized exercise prescription is the cornerstone of management, informed by phenotypic assessment and risk stratification. Interventions may be adjusted in frequency, intensity, modality, and progression to optimize benefit and minimize harm. For non-responders or high-risk phenotypes, adjunctive strategies—such as dietary modification, pharmacologic support, or alternative modalities (e.g., resistance vs. endurance training)—may be implemented. Multidisciplinary care, involving exercise physiologists, physical therapists, genetic counselors, and physicians, enhances adherence and outcome monitoring. Patient education and shared decision-making are essential to align interventions with individual preferences, values, and goals.

Recent Advances / Emerging Therapies

Recent advances in omics technologies and machine learning have revolutionized exercise response phenotyping. Integration of multi-omics data (genomics, proteomics, metabolomics) enables identification of novel biomarkers predictive of responsiveness. Artificial intelligence-driven algorithms can stratify individuals into response clusters, guiding personalized intervention design. Wearable technology and remote monitoring facilitate real-time data collection and adaptive feedback, supporting dynamic optimization of exercise regimens. Additionally, gene editing and targeted molecular therapies hold promise for modulating exercise responsiveness in select populations.

Guideline Recommendations

Current guidelines from organizations such as the American College of Sports Medicine and European Society of Cardiology endorse individualized exercise prescription, emphasizing baseline risk assessment and ongoing monitoring. Recommendations include routine phenotypic assessment, incorporation of genetic and biomarker data where feasible, and adaptation of protocols based on observed response. Clinicians are encouraged to document and report non-responders or adverse responders, contributing to the growing evidence base and refinement of practice guidelines. Further research is needed to formalize phenotyping protocols and validate predictive algorithms across diverse populations.

Conclusion

Exercise response phenotyping offers a transformative approach to individualized care, bridging the gap between population-level evidence and patient-centered outcomes. By integrating genetic, molecular, and clinical data, clinicians can better predict, monitor, and optimize therapeutic responses to exercise interventions. Ongoing research, technological innovation, and guideline development will further enhance the precision and efficacy of exercise-based therapies, ultimately improving health outcomes across diverse patient populations.